Skip to content

APOTHEEK BOURGUIGNON-DERAEVE: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK BOURGUIGNON-DERAEVE

BE 0467.752.608
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€439,701
2024 · €440,143-€442
Equity
€5.0m
2024 · €4.6m+€439,701
Cash
€2.0m
2024 · €1.1m+€916,187
Balance sheet total
€5.3m
2024 · €5.3m+€83,818

Largest movements

2024 to 2025
Assets
  • Cash +€916,187

    up €916,187 (+83.4%), from €1.1m to €2.0m

    mainly Current investments (+€845,481) and Net result for the year (+€439,701)

  • Current investments -€845,481

    down €845,481 (-32.4%), from €2.6m to €1.8m

Equity and liabilities
  • Other debts -€470,609

    no longer reported in 2025 (was €470,609)

  • Reserves +€439,701

    up €439,701 (+9.7%), from €4.5m to €5.0m

  • Tax, wage and social debts +€92,541

    up €92,541 (+271%), from €34,199 to €126,740

    of which Taxes: +€91,279

Income statement
  • Gross operating margin +€24,975

    up €24,975 (+2.2%), from €1.1m to €1.2m

  • Taxes +€23,168

    up €23,168 (+10.4%), from €222,574 to €245,743

  • Staff costs +€14,456

    up €14,456 (+3.2%), from €456,597 to €471,053

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €440,143
Gross operating margin +€24,975
Staff costs -€14,456
Depreciation -€7,831
Provisions +€9,126
Other operating charges +€577
Financial income +€9,793
Financial charges +€543
Taxes -€23,168
Result 2025 €439,701
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€127,745
Investment +€788,442
Financing €0
Cash 2024 €1.1m
Net result for the year +€439,701
Depreciation +€89,814
Stocks and contracts -€15,948
Receivables within one year -€24,548
Deferred charges and accrued income -€5,391
Trade debts +€22,185
Tax, wage and social debts +€92,541
Other debts -€470,609
Investment in fixed assets (net) -€57,038
Current investments +€845,481
Cash 2025 €2.0m
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €5,255,872 €5,339,690 +€83,818 +1.6%
Fixed assets 21/28 €553,947 €521,172 -€32,776 -5.9%
Tangible fixed assets 22/27 €553,947 €521,172 -€32,776 -5.9%
Land and buildings 22 €531,219 €464,474 -€66,746 -12.6%
Plant, machinery and equipment 23 €17,540 €32,922 +€15,381 +87.7%
Furniture and vehicles 24 €5,188 €23,776 +€18,588 +358%
Current assets 29/58 €4,701,924 €4,818,518 +€116,594 +2.5%
Stocks and contracts in progress 3 €636,120 €652,068 +€15,948 +2.5%
Stocks 30/36 €636,120 €652,068 +€15,948 +2.5%
Amounts receivable within one year 40/41 €355,070 €379,618 +€24,548 +6.9%
Trade receivables 40 €355,070 €379,618 +€24,548 +6.9%
Current investments 50/53 €2,612,395 €1,766,914 -€845,481 -32.4%
Cash at bank and in hand 54/58 €1,098,340 €2,014,527 +€916,187 +83.4%
Deferred charges and accrued income 490/1 - €5,391 +€5,391
Total equity and liabilities 10/49 €5,255,872 €5,339,690 +€83,818 +1.6%
Equity 10/15 €4,555,242 €4,994,943 +€439,701 +9.7%
Contributions 10/11 €24,789 €24,789 = 0.0%
Capital 10 €24,789 €24,789 = 0.0%
Issued capital 100 €24,789 €24,789 = 0.0%
Reserves 13 €4,530,453 €4,970,154 +€439,701 +9.7%
Non-distributable reserves 130/1 €4,530,453 €4,970,154 +€439,701 +9.7%
Legal reserve 130 €2,479 €2,479 = 0.0%
Other 1319 €4,527,974 €4,967,675 +€439,701 +9.7%
Amounts payable 17/49 €700,630 €344,747 -€355,883 -50.8%
Amounts payable within one year 42/48 €700,630 €344,747 -€355,883 -50.8%
Trade debts 44 €195,822 €218,007 +€22,185 +11.3%
Suppliers 440/4 €195,822 €218,007 +€22,185 +11.3%
Taxes, remuneration and social security 45 €34,199 €126,740 +€92,541 +271%
Taxes 450/3 €15,879 €107,158 +€91,279 +575%
Remuneration and social security 454/9 €18,320 €19,581 +€1,262 +6.9%
Other amounts payable 47/48 €470,609 - -€470,609
Remuneration, social security and pensions 62 €456,597 €471,053 +€14,456 +3.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €81,983 €89,814 +€7,831 +9.6%
Provisions for liabilities and charges: additions (uses and reversals) 635/8 €9,126 - -€9,126
Other operating charges 640/8 €12,048 €11,471 -€577 -4.8%
Gross operating margin 9900 €1,148,557 €1,173,532 +€24,975 +2.2%
Operating profit (loss) 9901 €588,804 €601,194 +€12,391 +2.1%
Financial income 75/76B €75,880 €85,673 +€9,793 +12.9%
Recurring financial income 75 €75,880 €85,673 +€9,793 +12.9%
Financial charges 65/66B €1,966 €1,424 -€543 -27.6%
Recurring financial charges 65 €1,966 €1,424 -€543 -27.6%
Profit (loss) for the period before taxes 9903 €662,717 €685,443 +€22,726 +3.4%
Income taxes 67/77 €222,574 €245,743 +€23,168 +10.4%
Profit (loss) for the period 9904 €440,143 €439,701 -€442 -0.1%
Profit (loss) for the period to be appropriated 9905 €440,143 €439,701 -€442 -0.1%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.